APA (7th ed.) Citation

Paré-Brunet, L., Sebio, A., Salazar, J., Berenguer-Llergo, A., Río, E., Barnadas, A., . . . Páez, D. (2015). Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy. Pharmacogenomics Journal, 15(5), 397. https://doi.org/10.1038/tpj.2015.1

Chicago Style (17th ed.) Citation

Paré-Brunet, L., A. Sebio, J. Salazar, A. Berenguer-Llergo, E. Río, A. Barnadas, M. Baiget, and D. Páez. "Genetic Variations in the VEGF Pathway as Prognostic Factors in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin-based Chemotherapy." Pharmacogenomics Journal 15, no. 5 (2015): 397. https://doi.org/10.1038/tpj.2015.1.

MLA (9th ed.) Citation

Paré-Brunet, L., et al. "Genetic Variations in the VEGF Pathway as Prognostic Factors in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin-based Chemotherapy." Pharmacogenomics Journal, vol. 15, no. 5, 2015, p. 397, https://doi.org/10.1038/tpj.2015.1.